Using a breast cancer metastasis in vivo mouse model, we showed that our bifunctional D10-Fc-TβRII-ED based trap, but not the version lacking the D10 motif, homes to and accumulates in the bone, leading to a reduction in the formation of osteolytic bone lesions. This evidence concerns the gene TGFBR2 and breast cancer.